Peripheral primitive neuroectodermal tumor (pPNET) is a rare, small, round cell malignancy that appears to develop from neuroectodermal cells 1 in children and young adults. Also, now included in the pPNET-Ewing's sarcoma family are extra-osseous Ewing's sarcoma, peripheral neuroepithelioma, Askin's tumor of the thoracopulmonary wall, and peripheral neuroblastoma.
Peripheral primitive neuroectodermal tumor (pPNET) is a rare, small, round cell malignancy that appears to develop from neuroectodermal cells 1 in children and young adults. Also, now included in the pPNET-Ewing's sarcoma family are extra-osseous Ewing's sarcoma, peripheral neuroepithelioma, Askin's tumor of the thoracopulmonary wall, and peripheral neuroblastoma. 2 Only four cases of pPNET arising from small bowel mesentery have been reported. [3] [4] [5] [6] It is known that tumors of neural crest origin show bidirectional or multidirectional differentiation. [7] [8] [9] To the best of our knowledge, there has been no report of pPNET showing osteoid and bone production. A case which presented with severe acute abdominal pain due to a ruptured tumor is reported herein. This pPNET case developed from the small bowel mesentery with osteoid and bone formation. One year after surgery, recurrent tumor was resected, and osteogenesis persisted.
CASE REPORT
A 23-year-old man was referred to Inha University Hospital due to severe abdominal pain. Computed tomography revealed an ovoid solid and cystic tumor in the pelvic cavity, measuring 11.0×6.0 cm. Emergency surgery was performed, and a large ruptured mass was found in the jejunal mesentery, 1 cm from the ligament of Treitz. The tumor involved the jejunal wall, and another mass the size of a thumb was detected within the porta hepatis. Disseminated miliary nodules were present in the greater omentum, the right colonic gutter, and the pelvic peritoneum. Segmental resection of the small intestine and omentectomy were performed. Postoperative laboratory examination revealed normal levels of serum lactate dehydrogenase, cancer antigen 125, and carcinoembryonic antigen, and postoperative positron emission tomography computed tomography was nor-mal. After operation, chemotherapy (vincristine, ifosfamide, etoposide, and doxorubicin) was performed. One year after the operation, a 10 cm, locally recurrent mesenteric mass was resected.
Macroscopically, a tumor measuring 12.0×8.0×7.5 cm was located in the mesentery of jejunum. Rupture was seen in the surface of tumor. The tumor showed a whitish-pink solid cut surface with foci of hemorrhage, extensive necrosis, and myxoid change. The jejunal wall was involved directly by the tumor and contained focal mucosal ulceration. The cut surface was whitegray and dense (Fig. 1) .
Microscopically, the entire wall of the jejunum contained tumor cells which also proliferated within the mesentery. The mucosa of the jejunum was involved by the tumor with surface erosion (Fig. 2A) . Small round cells containing uniform vesicular, round or oval nuclei, scanty clear, or eosinophilic cytoplasms and indistinct cytoplasmic borders comprised the tumor in sheet or lobule formation (Fig. 2B) . Often, intermingled spindle-shaped cells were found. Though some cells had a single prominent nucleolus, most cells had indistinct nucleoli. Well-formed Homer-Wright rosettes were frequently observed (Fig. 2B ). FlexnerWintersteiner rosettes did not exist, but perivascular pseudorosettes were occasionally seen. The tumor contained concentrated mild desmoplastic stromal changes. Mitotic figures were present in approximately 35 per 10 high-powered fields. Areas of production of osseous matrix with calcification and partly wellformed bony trabeculae were observed (Fig. 3A) . The osteogenic area was not more than 1% of the tumor. Although cytologically malignant cells were admixed with this osteogenic area, benign metaplastic bone formation was suspected, because the atypical cells were present only in the peripheral portion of the osteoid ( Fig. 3B ) and positive for CD99. The osteogenic area, in contrast, was CD99 negative. The pathologic findings of the metastatic lesions of the omental mass were identical to those of the primary mesenteric mass. Cytoplasmic glycogen was undetected in the tumor cells when pretreated with and without diastase in periodic acid-Schiff reactions. No cytoplasmic reactivity was found with Grimelius and Masson-Fontana staining.
Positive CD99 (MIC2), CD57, and neuron-specific enolase identified many tumor cells immunohistochemically (Fig. 4) , whereas positive vimentin and neurofilament results were also present in some cells. Synaptophysin, chromogranin, desmin, cytokeratin, S-100, CD117, and leukocyte common antigen were all absent in the tumor cells. Using dual color break-apart Ewing's sarcoma probing, fluorescence in situ hybridization (FISH) was performed on sections of the tissues that were formalin-fixed and paraffin embedded (Vysis, Downers Grove, IL, USA) with a mixture of 2 FISH DNA pro bes. The first was a 500-kb probe, labeled in the spectrum orange, and flanking the 5´ side of the Ewing sarcoma breakpoint region 1 (EWSR1) gene. The second probe, which flanked the 3´ end of the EWSR1 gene, was a 1,100-kb probe, utilizing a spectrum green label. Introns 7 through 10, used as restrictions within the EWSR1 gene, were the known break points. FISH showed a split signal pattern (one green and one orange) in interphase nuclei which was indicative of a EWSR1 gene rearrangement (Fig. 5) . A pPNET of the small bowel mesentery diagnosis was ascribed to the lesion, given these results.
The recurrent tumor resected one year after surgery, revealed similar histologic features: a typical small round cell tumor with rosette formation and metaplastic bone formation (Fig. 6) . The bony islands were more mature than the primary tumor.
DISCUSSION
The entire body is vulnerable to peripheral primitive neuroectodermal tumor invasion. The primary sites of pPNET are, in descending frequency, the chest wall, pelvis, retroperitoneum, abdomen, limb, and neck. 10 In viscera, distinct cases of pPNET have been studied. [3] [4] [5] [6] However, in the English literature, only one case of pPNET of the mesentery was reported with perforation at presentation as was presented in our case study. 4 pPNET prognosis is poor despite combined surgical, chemotherapeutic, and irradiation therapies. Only 25% of patients with tumors greater than 5 cm survive to 24 months according to Kushner et al. 10 Histologically, Homer-Wright or Flexner-Wintersteiner rosettes and perivascular pseudorosettes may form from undifferentiated small round cells which constitute pPNET. Fibrosarcoma or malignant peripheral nerve sheath tumors, small cell undifferentiated carcinomas, and carcinoid tumors may resemble some areas within the lesions. It is known that tumors of neural crest origin can show bidirectional or multidirectional differentiation. [7] [8] [9] Additionally, glial, ependymal, cartilaginous, and epithelial elements, though rare, have been found associated within pPN-ET. [7] [8] [9] Hachitanda et al. 11 reported a case of pPNET with epithelial and glial differentiation, and they suggested that the neoplastic neuroectodermal tissue can display a spectrum of differentiation. Although there has been no report of pPNET showing osteoid and bone production, it is thought that osteogenesis is a kind of differentiation of the tumor. Its prognostic implication is uncertain. Although several cases of bone and/or cartilage forming sarcomas have been reported in the literature, [12] [13] [14] [15] bone-forming pPNET has not.
Most authors agree that a useful tool in diagnosing pPNET immunohistochemically is CD99 (MIC2), which recognizes a 30/32 kDa surface glycoprotein. 16 This marker is found in more than 90% of pPNET cases. Yet, many tumors, such as malignant lymphoma, leukemia, gastrointestinal stromal tumor, and small cell carcinoma, may demonstrate CD99 expression. [17] [18] [19] [20] Regarding pediatric malignant lymphoma and leukemia of Tcell lineage, Riopel et al. 17 reported that CD99 expression was not uncommon.
The most objective diagnostic tool for pPNET is now considered to be karyotypic analysis for t(11;22)(q24;q12) translocation. 2, 16 This translocation occurs in more than 87% of the pPNET-Ewing's sarcoma cases. The detection of EWS/FLI-1 chimeric mRNA originating from the t(11;22)(q24;q12) translocation of the pPNET-Ewing's sarcoma family, facilitated by reverse transcription-polymerase chain reactions, have been reported in recent studies. 2 Other small round cell tumors, including malignant lymphoma, leukemia (granulocytic sarcoma), rhabdomyosarcoma, leiomyosarcoma, gastrointestinal stromal tumor, desmoplastic small round cell tumor, malignant mesothelioma, undifferentiated carcinoma, small cell carcinoma, and conventional neuroblastoma offer a differential diagnosis of the current lesion being discussed. Through histological, histochemical, immunohistochemical and molecular methods, the lesion was meticulously examined to maintain distinction. Immunohistochemical staining with desmin, smooth muscle actin, CD34, cytokeratin, leukocyte common antigen, CD117, and CD99 were used to exclude the diagnosis of other small round cell tumors and gastrointestinal stromal tumors. In addition, chromosomal rearrangements involving the EWSR1 gene on chromosome 22q12 was detected by FISH, which was a strong supportive finding for pPNET. Most of the mass at the primary site was found in the mesentery of the jejunum. Direct invasion of the jejunal wall was also present, yet despite the large size of the tumor (12.0×8.0 cm), the degree of involvement of the mucosa of the jejunum was relatively limited. A final diagnosis of pPNET of the jejunal mesentery was applied to this tumor.
In conclusion, we have reported the first case of pPNET with osteoid and bone formation, arising from the mesentery of the small bowel with rupture at onset. The rupture was considered to be caused by local ischemic change, necrosis, and massive hemorrhage. Intraabdominal pPNET may present with acute abdomen and may reveal osteoid and bone formation, which leads to a high degree of importance for both surgeons and pathologists to consider.
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